The Current State of Clinical Mycology in Eastern and South-Eastern Europe - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue Medical Mycology Année : 2022

The Current State of Clinical Mycology in Eastern and South-Eastern Europe

Esther Segal
  • Fonction : Auteur

Résumé

The ability of medical centres in Eastern and South-Eastern Europe to diagnose and treat fungal infections remains unknown. In order to investigate that, here we conducted a cross-sectional online survey, released at both The International Society for Human and Animal Mycology (ISHAM) and European Confederation of Medical Mycology (ECMM) websites. A total of 31 institutions responded to the questionnaire. Most centres (87.1%, n = 27) had access to Aspergillus spp. ELISA galactomannan testing as well as to Cryptococcus spp. antigen testing (83.9%, n = 26). Serological tests were mostly available for Aspergillus species (80.6%, n = 25); and most institutions reported access to mould-active antifungal drugs (83.9%; n = 26), but 5-flucytosine was available to only 29% (n = 9) of the participant centres. In conclusion, this study represents the first attempt to document the strengths and limitations of the Eastern and South-Eastern European region for diagnosing and treating fungal diseases.
Fichier principal
Vignette du fichier
Driemeyeret al-2022-The Current State of Clinical Mycology in Eastern and South-Eastern (1).pdf (591.5 Ko) Télécharger le fichier
Origine : Fichiers produits par l'(les) auteur(s)

Dates et versions

hal-03610807 , version 1 (06-05-2022)

Licence

Paternité - Pas d'utilisation commerciale

Identifiants

Citer

Cândida Driemeyer, Diego R Falci, Martin Hoenigl, Oliver A Cornely, Arunaloke Chakrabarti, et al.. The Current State of Clinical Mycology in Eastern and South-Eastern Europe. Medical Mycology, 2022, 60 (4), ⟨10.1093/mmy/myac017⟩. ⟨hal-03610807⟩
90 Consultations
106 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More